Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000146.xml
Diabetes aktuell 2022; 20(01): 36-42
DOI: 10.1055/a-1753-3875
DOI: 10.1055/a-1753-3875
Schwerpunkt
Metabolische und mentale Folgen der Pandemie
Zeit zu Handeln
ZUSAMMENFASSUNG
Als Hausärzte und Diabetologen werden wir in den nächsten Jahren mit den Langzeitfolgen der Pandemie zu tun haben. Neben der Viruserkrankung selbst haben die Maßnahmen zur Pandemiebekämpfung bisher noch nicht absehbare Kollateralschäden verursacht. Berichte und Studien aus allen Ländern, in denen es zu Lockdowns, Ausgangssperren, Homeoffice und Schul- bzw. Kitaschließungen kam, zeigen eine signifikante Zunahme an Übergewicht, Essstörungen, Depressionen und Angststörungen in allen Bevölkerungs- und Altersgruppen. Hierbei sind sowohl die Infizierten als auch die Nichtinfizierten betroffen. Die damit zusammenhängenden Langzeitfolgen werden unser Gesundheitssystem nachhaltig beanspruchen. Besonders bedenklich ist dabei die Tatsache, dass insbesondere die jetzige Pandemie auf die bereits vorbestehende „Pandemie“ von Übergewicht und Diabetes aufgebaut hat. Wir erzeugen damit eine weitere Zunahme der größten Risikogruppe für schwere Verläufe der Infektionskrankheiten in der Zukunft. Daher sind wir nun alle, ob im primären oder tertiären Teil der Krankenversorgungstätigkeit gefordert, dieser Post-Corona-Welle an metabolischen und mentalen Komplikationen zu begegnen. Als Ärzte müssen wir auf diese Folgen hinweisen und ausreichend Ressourcen zur Versorgung dieser dramatischen „Nachwehen“ der Pandemie schaffen. Daher ist es von großer Bedeutung, das Bewusstsein für die Schnittstelle zwischen mentalen Krankheiten, Diabetes und COVID-19 zu stärken. Da sich die Symptome von Post-COVID, Diabetes und Depression überschneiden können, besteht schließlich Bedarf an der Ausbildung von Fachpersonal in der Behandlung dieser Komorbiditäten.
Publication History
Article published online:
24 February 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204-1222 DOI: 10.1016/S0140-6736(20)30925-9.
- 2 Mekonen T, Chan GCK, Connor JP. et al Estimating the global treatment rates for depression: A systematic review and meta-analysis. J Affect Disord 2021; 295: 1234-1242 DOI: 10.1016/j.jad.2021.09.038.
- 3 Baker RE, Mahmud AS, Miller IF. et al Infectious disease in an era of global change. Nat Rev Microbiol 2021: 1-13 DOI: 10.1038/s41579-021-00639-z
- 4 Steenblock C, Schwarz PEH, Ludwig B. et al COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol 2021; 9: 786-798 DOI: 10.1016/S2213-8587(21)00244-8.
- 5 Lotfaliany M, Bowe SJ, Kowal P. et al Depression and chronic diseases: Co-occurrence and communality of risk factors. J Affect Disord 2018; 241: 461-468 DOI: 10.1016/j.jad.2018.08.011.
- 6 Saeedi P, Petersohn I, Salpea P. et al and Committee IDFDA. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2019; 157: 107843 DOI: 10.1016/j.diabres.2019.107843.
- 7 Pouwer F, Schram MT, Iversen MM. et al How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes. Diabet Med 2020; 37: 383-392 DOI: 10.1111/dme.14227.
- 8 Abdel-Bakky MS, Amin E, Faris TM, Abdellatif AAH. Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review). Mol Med Rep 2021; 24: 839 DOI: 10.3892/mmr.2021.12479.
- 9 Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol 2019; 56: 631-650 DOI: 10.1007/s00592-019-01295-9.
- 10 Messina R, Iommi M, Rucci P. et al Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study. Acta Diabetol 2022; 59: 95-104 DOI: 10.1007/s00592-021-01791-x.
- 11 Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012; 142 Suppl S8-S21 DOI: 10.1016/S0165-0327(12)70004-6.
- 12 Wang F, Wang S, Zong QQ. et al Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies. Diabet Med 2019; 36: 961-969 DOI: 10.1111/dme.14042.
- 13 Knol MJ, Twisk JW, Beekman AT. et al Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006; 49: 837-845 DOI: 10.1007/s00125-006-0159-x.
- 14 Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 2013; 74: 31-37 DOI: 10.4088/JCP.12r07922.
- 15 Holt RI, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep 2014; 14: 491 DOI: 10.1007/s11892-014-0491-3.
- 16 Hoogendoorn CJ, Roy JF, Gonzalez JS. Shared Dysregulation of Homeostatic Brain-Body Pathways in Depression and Type 2 Diabetes. Curr Diab Rep 2017; 17: 90 DOI: 10.1007/s11892-017-0923-y.
- 17 Berger I, Werdermann M, Bornstein SR, Steenblock C. The adrenal gland in stress – adaptation on a cellular level. J Steroid Biochem Mol Biol 2019; 190: 198-206 DOI: 10.1016/j.jsbmb.2019.04.006.
- 18 McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000; 22: 108-124 DOI: 10.1016/S0893-133X(99)00129-3.
- 19 Belvederi Murri M, Pariante C, Mondelli V. et al HPA axis and aging in depression: systematic review and meta-analysis. Psychoneuroendocrinology 2014; 41: 46-62 DOI: 10.1016/j.psyneuen.2013.12.004.
- 20 Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011; 73: 114-126 DOI: 10.1097/PSY.0b013e31820ad12b.
- 21 Bellass S, Lister J, Kitchen CEW. et al Living with diabetes alongside a severe mental illness: A qualitative exploration with people with severe mental illness, family members and healthcare staff. Diabet Med 2021; 38: e14562 DOI: 10.1111/dme.14562.
- 22 Simayi A, Mohemaiti P. Risk and protective factors of co-morbid depression in patients with type 2 diabetes mellitus: a meta analysis. Endocr J 2019; 66: 793-805 DOI: 10.1507/endocrj.EJ18-0579.
- 23 Fung ACH, Tse G, Cheng HL. et al Depressive Symptoms, Co-Morbidities, and Glycemic Control in Hong Kong Chinese Elderly Patients With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne) 2018; 9: 261 DOI: 10.3389/fendo.2018.00261.
- 24 Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol 2014; 6: a009191 DOI: 10.1101/cshperspect.a009191.
- 25 Esser N, Legrand-Poels S, Piette J. et al Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014; 105: 141-150 DOI: 10.1016/j.diabres.2014.04.006.
- 26 Bornstein SR, Rubino F, Ludwig B. et al Consequences of the COVID-19 pandemic for patients with metabolic diseases. Nat Metab 2021; 3: 289-292 DOI: 10.1038/s42255-021-00358-y.
- 27 Gregory JM, Slaughter JC, Duffus SH. et al COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021; 44: 526-532 DOI: 10.2337/dc20-2260.
- 28 Khunti K, Del Prato S, Mathieu C. et al COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care 2021; 44: 2645-2655 DOI: 10.2337/dc21-1318.
- 29 Alsadhan I, Alruwashid S, Alhamad M. et al Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series. Curr Ther Res Clin Exp 2020; 93: 100609 DOI: 10.1016/j.curtheres.2020.100609.
- 30 Heaney AI, Griffin GD, Simon EL. Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection. Am J Emerg Med 2020; 38: 2491 e3-2491 e4 DOI: 10.1016/j.ajem.2020.05.114.
- 31 Hollstein T, Schulte DM, Schulz J. et al Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab 2020; 2: 1021-1024 DOI: 10.1038/s42255-020-00281-8.
- 32 Li J, Wang X, Chen J. et al COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab 2020; 22: 1935-1941 DOI: 10.1111/dom.14057.
- 33 Montefusco L, Ben Nasr M. et al Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab 2021; 3: 774-785 DOI: 10.1038/s42255-021-00407-6.
- 34 Naguib MN, Raymond JK, Vidmar AP. New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19. J Pediatr Endocrinol Metab 2021; 34: 147-150 DOI: 10.1515/jpem-2020-0426.
- 35 Rubino F, Amiel SA, Zimmet P. et al New-Onset Diabetes in Covid-19. N Engl J Med 2020; 383: 789-790 DOI: 10.1056/NEJMc2018688.
- 36 Laurenzi A, Caretto A, Molinari C. et al No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection. J Clin Endocrinol Metab. 2021 DOI: 10.1210/clinem/dgab792
- 37 Muller JA, Gross R, Conzelmann C. et al SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab 2021; 3: 149-165 DOI: 10.1038/s42255-021-00347-1.
- 38 Steenblock C, Richter S, Berger I. et al Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun 2021; 12: 3534 DOI: 10.1038/s41467-021-23886-3.
- 39 Wu CT, Lidsky PV, Xiao Y. et al SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab 2021; 33: 1565-1576 DOI: 10.1016/j.cmet.2021.05.013.
- 40 Zinserling VA, Bornstein SR, Narkevich TA. et al Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs. IDCases 2021; 26: e01328 DOI: 10.1016/j.idcr.2021.e01328.
- 41 Ornell F, Schuch JB, Sordi AO, Kessler FHP. „Pandemic fear“ and COVID-19: mental health burden and strategies. Braz J Psychiatry 2020; 42: 232-235 DOI: 10.1590/1516-4446-2020-0008.
- 42 Steenblock C, Todorov V, Kanczkowski W. et al Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol Psychiatry 2020; 25: 1611-1617 DOI: 10.1038/s41380-020-0758-9.
- 43 Cena H, Fiechtner L, Vincenti A. et al COVID-19 Pandemic as Risk Factors for Excessive Weight Gain in Pediatrics: The Role of Changes in Nutrition Behavior. A Narrative Review. Nutrients 2021; 13: 4255 DOI: 10.3390/nu13124255.
- 44 Dun Y, Ripley-Gonzalez JW, Zhou N. et al Weight gain in Chinese youth during a 4-month COVID-19 lockdown: a retrospective observational study. BMJ Open 2021; 11: e052451 DOI: 10.1136/bmjopen-2021-052451.
- 45 Kang HM, Jeong DC, Suh BK, Ahn MB. The Impact of the Coronavirus Disease-2019 Pandemic on Childhood Obesity and Vitamin D Status. J Korean Med Sci 2021; 36: e21 DOI: 10.3346/jkms.2021.36.e21.
- 46 Gilsbach S, Herpertz-Dahlmann B, Konrad K. Psychological Impact of the COVID-19 Pandemic on Children and Adolescents With and Without Mental Disorders. Front Public Health 2021; 9: 679041 DOI: 10.3389/fpubh.2021.679041.
- 47 Ocampo Gonzalez AA, Castillo Garcia JF, Pabon Sandoval LC. et al Depressive symptomatology in adults during the COVID-19 pandemic. J Investig Med 2022; 70: 436-445 DOI: 10.1136/jim-2021-001992.
- 48 Werner AM, Tibubos AN, Mulder LM. et al The impact of lockdown stress and loneliness during the COVID-19 pandemic on mental health among university students in Germany. Sci Rep 2021; 11: 22637 DOI: 10.1038/s41598-021-02024-5.
- 49 Jin Y, Sun T, Zheng P, An J. Mass quarantine and mental health during COVID-19: A meta-analysis. J Affect Disord 2021; 295: 1335-1346 DOI: 10.1016/j.jad.2021.08.067.
- 50 Docherty S, Haskell-Ramsay CF, McInnes L, Wetherell MA. The Effects of COVID-19 Lockdown on Health and Psychosocial Functioning in Older Adults Aged 70 and Over. Gerontol Geriatr Med. 2021 7. 23337214211039974 DOI: 10.1177/23337214211039974
- 51 Prekazi L, Hajrullahu V, Bahtiri S. et al The Impact of Coping Skills in Post-traumatic Growth of Healthcare Providers: When Mental Health Is Deteriorating Due to COVID-19 Pandemic. Frontiers in Psychology 2021: 12 DOI: 10.3389/fpsyg.2021.791568
- 52 Bulkes NZ, Davis K, Kay B, Riemann BC. Comparing efficacy of telehealth to in-person mental health care in intensive-treatment-seeking adults. J Psychiatr Res 2022; 145: 347-352 DOI: 10.1016/j.jpsychires.2021.11.003.
- 53 Rogers JP, Chesney E, Oliver D. et al Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020; 7: 611-627 DOI: 10.1016/S2215-0366(20)30203-0.
- 54 Liu J, Li S, Liu J. et al Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 2020; 55: 102763 DOI: 10.1016/j.ebiom.2020.102763.
- 55 Bourmistrova NW, Solomon T, Braude P. et al Long-term effects of COVID-19 on mental health: A systematic review. J Affect Disord 2021; 299: 118-125 DOI: 10.1016/j.jad.2021.11.031.
- 56 Dotan A, Shoenfeld Y. Post-COVID syndrome: the aftershock of SARS-CoV-2. Int J Infect Dis 2021; 114: 233-235 DOI: 10.1016/j.ijid.2021.11.020.
- 57 Splinter MJ, Velek P, Ikram MK. et al Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study. PLoS Med 2021; 18: e1003854 DOI: 10.1371/journal.pmed.1003854.
- 58 Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog 2013; 9: e1003467 DOI: 10.1371/journal.ppat.1003467.
- 59 Tucci V, Moukaddam N, Meadows J. et al The Forgotten Plague: Psychiatric Manifestations of Ebola, Zika, and Emerging Infectious Diseases. J Glob Infect Dis 2017; 9: 151-156 DOI: 10.4103/jgid.jgid_66_17.
- 60 Abas MA.. Combining active ingredients to treat depression in the wake of COVID-19. Lancet Psychiatry. 2021 DOI: 10.1016/S2215-0366(21)00436-3
- 61 Ai X, Yang J, Lin Z. Mental Health and the Role of Physical Activity During the COVID-19 Pandemic. Front Psychol 2021; 12: 759987 DOI: 10.3389/fpsyg.2021.759987.
- 62 Metoki H. (2021) The Significance of Observing the Risk of Non-communicable Diseases after Large-scale Disasters and Communicable Disease Epidemics. JMA J 2021; 4: 305-310 DOI: 10.31662/jmaj.2021-0126.